The Potential Use of Aptamers in The Process of Drug Development

被引：2
|
作者：
Gholikhani, Tooba [1 ,2 ,3 ]
Brito, Balam Jimenez [4 ]
Livingston, Frey [4 ]
Kumar, Shalen [5 ]
机构：
[1] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Pharm, Tabriz, Iran
[3] Nanora Pharmaceut, Tabriz, Iran
[4] Victoria Univ Wellington New Zealand, Sch Biol Sci, Wellington, New Zealand
[5] IQ Sci Ltd, Wellington, New Zealand
来源：
PHARMACEUTICAL SCIENCES | 2021年 / 27卷 / 04期
关键词：
Aptamers; Drug discovery; Drug development; SELEX; NUCLEIC-ACID APTAMERS; SYSTEMATIC EVOLUTION; GENERATION; THERAPEUTICS; ANTIBODIES; MOLECULES; SELECTION; LIGANDS; GROWTH; ASSAY;
D O I：
10.34172/PS.2021.17
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Single-stranded nucleic acids can fold and create unique 3-dimensional structures when interacting with other molecules. The unique structure can achieve high specificity and affinity for the particular target. Synthetic oligonucleotide binding agents, also known as aptamers, are generated through the rational process of Systematic Evolution of Ligands by Exponential Enrichment (SELEX). As this technology matures, it shows increasing promise for use in the field of therapeutic drugs, drug discovery, development, and delivery, and this report seeks to detail how this technology may be applied.
引用
收藏
页码：503 / 510
页数：8
相关论文
共 50 条
  • [21] Aptamer cocktails: Enhancement of sensing signals compared to single use of aptamers for detection of bacteria
    Kim, Yeon Seok
    Chung, Jinyang
    Song, Min Young
    Jurng, Jongsoo
    Kim, Byoung Chan
    BIOSENSORS & BIOELECTRONICS, 2014, 54 : 195 - 198
  • [22] The potential of aptamers for cancer research
    Zhou, Zhizhi
    Liu, Mingying
    Jiang, Jiahuan
    ANALYTICAL BIOCHEMISTRY, 2018, 549 : 91 - 95
  • [23] Synthetic antibodies for methamphetamine analysis: Design of high affinity aptamers and their use in electrochemical biosensors
    Bor, Gulsah
    Bulut, Umut
    Man, Ezgi
    Hanoglu, Simge Balaban
    Evran, Serap
    Timur, Suna
    JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 2022, 921
  • [24] Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
    Amero, Paola
    Khatua, Soumen
    Rodriguez-Aguayo, Cristian
    Lopez-Berestein, Gabriel
    CANCERS, 2020, 12 (10) : 1 - 29
  • [25] Nucleic Acid Aptamers as a Potential Nucleus Targeted Drug Delivery System
    Shrivastava, Garima
    Bakshi, Hamid A.
    Aljabali, Alaa A.
    Mishra, Vijay
    Hakkim, Faruck L.
    Charbe, Nitin B.
    Kesharwani, Prashant
    Chellappan, Dinesh K.
    Dua, Kamal
    Tambuwala, Murtaza M.
    CURRENT DRUG DELIVERY, 2020, 17 (02) : 101 - 111
  • [26] Clinical microdialysis: Current applications and potential use in drug development
    Brunner, Martin
    Derendorf, Hartmut
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2006, 25 (07) : 674 - 680
  • [27] Trends of Artificial Intelligence (AI) Use in Drug Targets, Discovery and Development: Current Status and Future Perspectives
    Mahapatra, Manmayee
    Sahu, Chittaranjan
    Mohapatra, Snehamayee
    CURRENT DRUG TARGETS, 2024,
  • [28] Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro
    Chakravarthy, Madhuri
    AlShamaileh, Hadi
    Huang, He
    Tannenberg, Rudi K.
    Chen, Suxiang
    Worrall, Simon
    Dodd, Peter R.
    Veedu, Rakesh N.
    CHEMICAL COMMUNICATIONS, 2018, 54 (36) : 4593 - 4596
  • [29] Tumor-Targeted Drug Delivery with Aptamers
    Zhang, Y.
    Hong, H.
    Cai, W.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (27) : 4185 - 4194
  • [30] Expanding the application potential of DNA aptamers by their functionalization
    Chumakov, A. M.
    Yuhina, E. S.
    Frolova, E. I.
    Kravchenko, J. E.
    Chumakov, S. P.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2016, 42 (01) : 1 - 13
12345